BioSpace News Archive

Acute or chronic sleep deprivation effects harm more than just your personal life. They have these significant side effects on your career which you shouldn’t overlook.

If you’re applying for multiple jobs at the same time, perhaps over several weeks or months, things can quickly spiral out of control. You can easily find yourself with 10 or 20 different versions of your resume or cover letter floating around on your desktop, requests for materials coming at you from every direction, and a long to-do list of follow-ups, thank you notes, and applications that need submitting.

Secarna’s proprietary antisense oligonucleotide platform LNAplusTM to be combined with MetP Pharma’s nasal drug delivery technology to develop novel treatment options for neurodegenerative diseases

Formulation issues cause significant drug project delays and project failures, as experienced by 60% of survey participants.

Advancing proprietary pipeline; solid progress in partnered programs

Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process

Society for Neuroscience Features OTO-413 Presentation as Neuroscience 2018 Hot Topic

Neos Therapeutics, Inc. today announced the pricing of an underwritten public offering of 17,391,304 shares of its common stock at a price to the public of $2.30 per share, before deducting underwriting discounts and commissions and other offering expenses payable by Neos.

New Data Continue to Reinforce IN.PACT Admiral DCB as a Durable, Frontline Option to Address Treatment Challenges in PAD

According to the resolution of the Annual General Meeting in BioArctic AB (publ) on May 15, 2018 the members of the Nomination Committee for the 2019 Annual General Meeting shall be appointed through a procedure where the three largest shareholders in terms of voting power according to Euroclear’s transcription of the share register as of September 30, 2018 are contacted by the Chairman of the Board and asked to appoint one representative each to the Nomination Committee.